Advertisement

BEVISPAS TABLETS

Main information

  • Trade name:
  • BEVISPAS TABLETS
  • Available from:
  • Lennon
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
Advertisement

Documents

Localization

  • Available in:
  • BEVISPAS TABLETS
    South Africa
  • Language:
  • English

Other information

Advertisement

Status

  • Source:
  • Sounth African Electronic Package Inserts
  • Last update:
  • 09-08-2016

Patient Information leaflet

Advertisement

BEVISPAS TABLETS

SCHEDULING STATUS:

S2

PROPRIETARY NAME

(and dosage form):

BEVISPAS TABLETS

COMPOSITION:

Each tablet contains: 135 mg mebeverine hydrochloride.

PHARMACOLOGICAL CLASSIFICATION:

A 11.2: Gastro-intestinal antispasmodics and cholinolytics.

PHARMACOLOGICAL ACTION:

Bevispas is a musculotropic spasmolytic agent with a selective action especially on smooth muscle spasms of the gastro-

intestinal tract. No significant inhibition of normal peristalsis has been observed.

INDICATIONS:

Primary irritable colon characterised by persistent diarrhoea, alternating constipation and diarrhoea, abdominal pain and

postprandial distension. Secondary irritable colon due to organic lesions such as diverticulitis, regional enteritis, specific

and non-specific inflammatory conditions of the gastro-intestinal tract.

CONTRA-INDICATIONS:

Hypersensitivity to any ingredient in the product. Patients with porphyria.

DOSAGE AND DIRECTIONS FOR USE:

135 mg mebeverine hydrochloride (one tablet) three times daily, preferably before meals. After a period of a few weeks

the dosage may be gradually reduced once the desired effect has been obtained. Mebeverine hydrochloride is not contra-

indicated in patients with glaucoma or prostatic hypertrophy, as atropine-like effects are absent.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:

Depression, headache, diarrhoea, constipation and dizziness have been reported after administration of Bevispas.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:

See Side Effects and Special Precautions. Treatment is symptomatic and supportive.

IDENTIFICATION:

A white biconvex film coated tablet engraved with a mortar and pestle on one side.

PRESENTATION:

Securitainer packs of 100 tablets.

Securitainer packs of 20 tablets.

Securitainer packs of 500 tablets.

STORAGE INSTRUCTIONS:

Store below 30°C in tightly closed containers. Protect from light.

KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:

29/11.2/0255

NAME AND BUSINESS ADDRESS OF APPLICANT:

Pharmacare Limited

Pharmacare Limited

7 Fairclough Road

PORT ELIZABETH

6001

DATE OF PUBLICATION OF THIS PACKAGE INSERT:

02/12/1994.

LENNON logo

D240

A & S PRINTERS .

Updated on this site: January 2001

Current: April 2005

Source: Community Pharmacy

30-8-2016

Ton Shen Health/Life Rising Expands Recalls of “DHZC-2 Tablet” to All Lots Purchased Before August 24 2016 Because of Possible Health Risk

Ton Shen Health/Life Rising Expands Recalls of “DHZC-2 Tablet” to All Lots Purchased Before August 24 2016 Because of Possible Health Risk

Ton Shen Health/Life Rising Corporation of Chicago, IL, is expanding its recall of DHZC-2 Tablets to all lots purchased before August 24, 2016 because they have the potential to be contaminated with elevated levels of lead.

FDA - U.S. Food and Drug Administration

29-8-2016

Dietary Supplements by Ton Shen Health/Life Rising: Recall - Elevated Lead Levels

Dietary Supplements by Ton Shen Health/Life Rising: Recall - Elevated Lead Levels

Recall expanded to include all lots of DHZC-2 tablets. Distribution of all Life Rising products on hold until September 1, 2016.

FDA - U.S. Food and Drug Administration

18-8-2016

Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution by Arbor Pharmaceuticals: Recall - Inadequate Seal of Blister Pack

Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution by Arbor Pharmaceuticals: Recall - Inadequate Seal of Blister Pack

Risk of sub-therapeutic dose as well as potential microbial contamination.

FDA - U.S. Food and Drug Administration

18-8-2016

Voluntary Nationwide Recall of Cetylev® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack

Voluntary Nationwide Recall of Cetylev® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack

Arbor Pharmaceuticals, LLC (Arbor) today announced a voluntary recall of three (3) lots of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, due to an inadequate seal of the blister pack. An inadequate seal could result in an increase of oxygen and moisture entering the blister cavity which can start the effervescent process. This results in enlarged and swelled tablets which could also completely dissolve within the blister pack.

FDA - U.S. Food and Drug Administration

12-8-2016

DHZC-2 Tablet by Ton Shen Health: Recall - Possible Health Risk

DHZC-2 Tablet by Ton Shen Health: Recall - Possible Health Risk

Tablets have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children.

FDA - U.S. Food and Drug Administration

12-8-2016

Ton Shen Health Recalls “DHZC-2 Tablet” Because of Possible Health Risk

Ton Shen Health Recalls “DHZC-2 Tablet” Because of Possible Health Risk

Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children. Lead poisoning can happen if a person is exposed to high levels of lead over short period of time.

FDA - U.S. Food and Drug Administration

28-7-2016

Foreign Product Alert: DR's Secret Bio Herbs Coffee, Exhilarate, Ultimate Nutrition Amino Gold (1000mg capsules, 1000mg tablets, 1500mg tablets), Michael's Naturopathic Programs Cholesterol Metabolism Factors

Foreign Product Alert: DR's Secret Bio Herbs Coffee, Exhilarate, Ultimate Nutrition Amino Gold (1000mg capsules, 1000mg tablets, 1500mg tablets), Michael's Naturopathic Programs Cholesterol Metabolism Factors

These foreign health products have been found by regulators in other countries to contain undeclared allergens and or undeclared drug ingredients.

Canada - Health Canada

13-7-2016

Foreign Product Alert: 3rd Degree, Black Gold X Advanced, The Body Shot Bar Step 2, Black Label X, Super Dragon capsules, Lang Yi Hao Tablets, Hai Leng Hai Beh Herbal Itch Removing Capsule

Foreign Product Alert: 3rd Degree, Black Gold X Advanced, The Body Shot Bar Step 2, Black Label X, Super Dragon capsules, Lang Yi Hao Tablets, Hai Leng Hai Beh Herbal Itch Removing Capsule

These foreign health products have been found by regulators in other countries to contain undeclared drug ingredients.

Canada - Health Canada

14-6-2016

Foreign Product Alert: Excellence Losing Weight capsules, Meizitang Botanical Slimming 100% Natural Soft Gel, Natural Model capsules, Boss Number #Six, Bull, Bull's Genital, Ginseng Power-X, Golden Night, Half Quite tablets, Maxagra capsules, Neophase Nat

Foreign Product Alert: Excellence Losing Weight capsules, Meizitang Botanical Slimming 100% Natural Soft Gel, Natural Model capsules, Boss Number #Six, Bull, Bull's Genital, Ginseng Power-X, Golden Night, Half Quite tablets, Maxagra capsules, Neophase Nat

Unauthorized foreign health products Product Name(s) Hazard(s) Identified Source of Alert Other product information, if available Images Unauthorized Weight Loss Products Excellence Losing Weight capsules Undeclared sibutramine Australian Therapeutic Goods Administration Meizitang Botanical Slimming 100% Natural Soft Gel Undeclared diclofenac Singapore Health S...

Canada - Health Canada

22-8-2016

Acetaminophen Overdose Antidote Cetylev Recalled

Acetaminophen Overdose Antidote Cetylev Recalled

Arbor Pharmaceuticals has recalled three lots of acetylcysteine (Cetylev) effervescent tablets for oral solution (500 mg) because of an inadequate seal of the blister pack, the US Food and Drug Administration (FDA) said today in a safety alert.

US - RxList

1-8-2016

Scientific guideline:  Draft abiraterone tablets 250 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft abiraterone tablets 250 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of abiraterone.

Europe - EMA - European Medicines Agency

1-8-2016

Scientific guideline:  Draft vandetanib film-coated tablets 100 and 300 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft vandetanib film-coated tablets 100 and 300 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of vandetanib.

Europe - EMA - European Medicines Agency

1-8-2016

Scientific guideline:  Draft vemurafenib film-coated tablets 240 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft vemurafenib film-coated tablets 240 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of vemurafenib.

Europe - EMA - European Medicines Agency

12-7-2016

MIRACLE GYN (2 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

MIRACLE GYN (2 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

Updated Date: Jul 12, 2016 EST

US - DailyMed

12-7-2016

MIRACLE GYN (10 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

MIRACLE GYN (10 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

Updated Date: Jul 12, 2016 EST

US - DailyMed

12-7-2016

JILGYUNGYI (20 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

JILGYUNGYI (20 TABLETS) (Allantoin) Tablet [Haudongchun Co., Ltd.]

Updated Date: Jul 12, 2016 EST

US - DailyMed

8-7-2016

PRAC to Review Risks of Modified-Release Paracetamol

PRAC to Review Risks of Modified-Release Paracetamol

The the European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee (PRAC) will review the risks and benefits of modified- and prolonged-release paracetamol (acetaminophen) tablets, the agency said today.

US - RxList

24-6-2016

News and press releases:  EMA warns that Noxafil tablets and oral suspension have different doses and are not interchangeable

News and press releases: EMA warns that Noxafil tablets and oral suspension have different doses and are not interchangeable

Prescriptions should indicate which dose form is intended

Europe - EMA - European Medicines Agency

11-6-2016

Parents Often Using TVs, Tablets as 'Electronic Babysitters'

Parents Often Using TVs, Tablets as 'Electronic Babysitters'

Title: Parents Often Using TVs, Tablets as 'Electronic Babysitters'Category: Health NewsCreated: 6/10/2016 12:00:00 AMLast Editorial Review: 6/10/2016 12:00:00 AM

US - MedicineNet

6-6-2016

CARBIDOPA TABLETS, 25 MG (Carbidopa Tablets, 25 Mg) Tablet [AvKARE, Inc.]

CARBIDOPA TABLETS, 25 MG (Carbidopa Tablets, 25 Mg) Tablet [AvKARE, Inc.]

Updated Date: Jun 6, 2016 EST

US - DailyMed

Other products with the same active ingredient

Other products from the same company

Advertisement